コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e C-terminus of Sema3F with the b1 domain of neuropilin.
2 al domain of semaphorin and the b1 domain of neuropilin.
3 hat potently inhibits the binding of VEGF to neuropilin.
4 tC signal independently of the Robos and the Neuropilins.
5 e known primarily as ligands for plexins and neuropilins.
6 that acts through a mechanism distinct from neuropilins.
7 nteraction with their receptors, plexins and neuropilins.
8 s 1 (GIPC1, aka Synectin) interacts with the neuropilins.
10 ead, we found that ANGPTL4 binds directly to neuropilin 1 (NRP1) and NRP2 on endothelial cells (ECs),
12 BMA nucleus, owing to reduced expression of neuropilin 1 (Nrp1) and Nrp2, two semaphorin receptors t
14 mall molecule ligand for the VEGF-A receptor neuropilin 1 (NRP1) and the structural characterization
15 demonstrate that beta8 integrin (Itgb8) and neuropilin 1 (Nrp1) cooperatively promote CNS angiogenes
16 Moreover, high expression of PlGF receptor neuropilin 1 (Nrp1) correlates with poor overall surviva
18 tion, bevacizumab decreased Ang1 and induced neuropilin 1 (NRP1) expression in tumor-associated macro
19 semaphorin SEMA3C, and their shared receptor neuropilin 1 (NRP1) in OFT development, the precise mech
25 analyses with in vitro assays, we show that neuropilin 1 (NRP1) promotes contralateral RGC projectio
27 by endothelial cells where it partners with neuropilin 1 (Nrp1) to form a functional receptor for th
32 ssel growth, endothelial cells (ECs) express neuropilin 1 (NRP1), and NRP1 associates with the recept
33 f these targets is the guidance cue receptor Neuropilin 1 (Nrp1), which is sensitive to the repellent
38 aging, as well as suggest miR-208a, AT2R and neuropilin 1 as potential therapeutic targets and mechan
39 Factor (VEGF)-dependent, proangiogenic GIPC1-Neuropilin 1 complex, recasting GIPCs as negative modula
40 study highlights the proangiogenic receptor neuropilin 1 in macrophages and microglial cells in glio
43 betic female rats have reduced expression of neuropilin 1 that attenuates cardiomyopathy compared to
44 uterus-draining lymph nodes, comprising 70% neuropilin 1(+) tTregs and 30% neuropilin 1(-) pTregs.
46 iple combination of selection markers--CD34, neuropilin 1, and human kinase insert domain-containing
47 actor (VEGF), VEGF receptors, semaphorin 3F, neuropilin 1, neuropilin 2, podoplanin, and LYVE-1 by qu
48 evels of known A10 elevated genes, including neuropilin 1, neuropilin 2, slit2 and adenylyl cyclase-a
54 RPPR peptide, with affinity for the receptor neuropilin-1 (NRP), which is expressed on both endotheli
55 alpha(cont) and Gsalpha(KO) cells identified neuropilin-1 (Nrp-1) and granulin (Grn) as osteocytic-se
56 rived GBM cells expressing shRNAs of VEGF or neuropilin-1 (NRP-1) attenuate cancer stem cell markers,
57 that must be C-terminally exposed to trigger neuropilin-1 (NRP-1) binding, cellular internalization a
59 eport that expression of the VEGF coreceptor neuropilin-1 (NRP-1) coincides with expression of Brachy
60 actor (VEGF) and semaphorin-binding receptor Neuropilin-1 (Nrp-1) emerge as crucial determinants of M
62 Heparin/heparan sulfate proteoglycans and neuropilin-1 (NRP-1) have been identified as co-receptor
63 gated the role of semaphorin 3A (Sema3A) and neuropilin-1 (Nrp-1) in lymphatic vessel maturation and
64 that trafficking of the angiogenic receptor neuropilin-1 (NRP-1) is abrogated by the liver kinase B1
69 liver fibrosis, the axonal guidance molecule neuropilin-1 (NRP-1) was upregulated in activated HSCs,
70 , heparan sulfate proteoglycans (HSPGs), and neuropilin-1 (NRP-1) were demonstrated to facilitate HTL
71 and conditional knockout mice, we show that neuropilin-1 (NRP-1), a known receptor of VEGF, is neces
73 we demonstrate that a cell surface molecule, neuropilin-1 (Nrp-1), is expressed at high levels on nT
74 th heparan sulfate proteoglycans (HSPGs) and neuropilin-1 (NRP-1), two molecules important for HTLV-1
85 ass spectrometry-based approach, we identify neuropilin-1 (NRP1) as a NE receptor that mediates uptak
88 rt that mice with a CD8(+) T cell-restricted neuropilin-1 (NRP1) deletion exhibited substantially enh
91 efine the role of transmembrane glycoprotein neuropilin-1 (NRP1) in the expression of DDAHs and inves
92 Sema4a) and the Treg-cell-expressed receptor neuropilin-1 (Nrp1) interact both in vitro, to potentiat
98 tion of circulating monocytes expressing the neuropilin-1 (Nrp1) receptor (Nrp1-expressing monocytes;
99 onset of Sema3A sensitivity and concomitant neuropilin-1 (NRP1) receptor expression and caused cell-
101 ligo G) reduce endothelial levels of surface neuropilin-1 (NRP1), a receptor shared by semaphorin 3A
104 disrupts the developmental downregulation of Neuropilin-1 (Nrp1), the receptor for Sema3A, in sensory
106 Mice that lack the transmembrane receptor neuropilin-1 (Nrp1), which modulates GAM immune polariza
107 e show this is a key endothelial function of neuropilin-1 (Nrp1), which suppresses the stalk-cell phe
110 dritic cell (pDC) marker, BDCA4, identifying neuropilin-1 (NRP1); and the helper T cell marker, CD4.
111 microenvironment by increasing the levels of neuropilin-1 (NRP1, a co-receptor of vascular endothelia
112 We also show that the semaphorin receptor neuropilin-1 acts cell-autonomously to control the devel
113 ration of siRNAs against the Sema3A receptor neuropilin-1 also resulted in polarization defects in vi
114 Patients with low baseline expression of neuropilin-1 also showed a trend toward improved overall
116 First, aged Tregs had high expression of neuropilin-1 and Helios, and had a broad Vbeta repertoir
118 ng of VEGF to low-affinity binding sites and neuropilin-1 and stimulates further growth factor recept
119 th factor A (VEGF-A) isoforms, expression of neuropilin-1 and VEGF receptor 1 in tumors or plasma, an
120 c vessel endothelial hyaluronan receptor 1), neuropilin-1 and VEGFR2 (vascular endothelial growth fac
121 force sensor and forms a mechanocomplex with neuropilin-1 and VEGFR2 that is necessary and sufficient
123 tivity of the CgA(1-373) was blocked by anti-neuropilin-1 antibodies as well as by nicotinic acetylch
127 matically removed in plasma, causing loss of neuropilin-1 binding and gain of antiangiogenic activity
130 CI, 0.59 to 0.97) versus patients with high neuropilin-1 expression (HR, 1.07; 95% CI, 0.81 to 1.40;
133 Baseline plasma VEGF-A levels and tumor neuropilin-1 expression were identified as potential pre
135 the translation of the guidance cue receptor Neuropilin-1 in RGCs, with Hermes knock-down resulting i
136 hosphorylation status and down-regulation of neuropilin-1 in the HemSCs demonstrate that VEGFR-2 and
137 e transfer experiments and the expression of neuropilin-1 indicate that these cells are predominantly
138 s a critical role for heparin-binding domain/Neuropilin-1 interaction and its regulation by plasmin p
141 surprise, we found that membrane-associated neuropilin-1 is polysialylated at approximately 50% of t
143 action between fragmented chromogranin A and neuropilin-1 is required for tumor growth and represents
147 ar tumor areas is regulated by Semaphorin 3A/Neuropilin-1 signaling; interference with this pathway e
150 implicate Sema3A as an autocrine signal for neuropilin-1 to promote GBM dispersal by modulating subs
151 stemmed from a failure to expand functional neuropilin-1(+) regulatory T (T reg) cells in the absenc
152 th, portal vessels undergo a transition from Neuropilin-1(+)Ephrin-B2(+) artery to EphB4(+) vein phen
154 ound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in
156 of domain swap chimeras with sequences from neuropilin-1, a protein for which polysialylation had no
157 r to those of others following inhibition of neuropilin-1, a receptor previously implicated in TGFbet
158 finity for its primary receptor and binds to neuropilin-1, activating a tissue penetration pathway th
159 ication of sialoglycoproteins such as CD105, neuropilin-1, and CLEC14A, which have already been descr
160 (VEGF) and three of its receptors, VEGFR-2, neuropilin-1, and neuropilin-2, in paraffin-embedded sam
161 wth factor-A (VEGF-A), protein expression of neuropilin-1, and VEGF receptors-1 and -2 (VEGFR-1 and V
162 express similar levels of Sema3A receptors (neuropilin-1, cell adhesion molecule L1, and plexinA4),
163 rent iNKT subsets defined by CD4, NK1.1, and neuropilin-1, indicating that distinct functional subpop
164 that VEGF immobilization, interactions with Neuropilin-1, perturbations of VEGFR2 trafficking, and c
165 gesting that these receptors, in addition to neuropilin-1, play a role in the proangiogenic activity
166 dipocytes, probably through up-regulation of neuropilin-1, the OB-mediated enhanced hematopoiesis fun
167 tor complex comprising VEGFR2, PlexinD1, and neuropilin-1, thereby preventing degradation of internal
168 njugate (a peptide that binds to the protein neuropilin-1, which is highly expressed in tumours, and
169 rnalized into cultured tumor cells through a neuropilin-1-activated pathway and triggered cell death.
170 nd tLyP-1 internalize into cells through the neuropilin-1-dependent CendR internalization pathway.
171 tissue permeability in a tumor-specific and neuropilin-1-dependent manner, allowing coadministered d
173 istic insights into the regulation of PlGF-2/Neuropilin-1-mediated tissue vascularization and growth.
175 pment and is not required for maintenance of neuropilin-1-positive natural Tregs in the periphery, it
176 h 2 (ba2), is due to chemoattraction through neuropilin-1-vascular endothelial growth factor (VEGF) i
187 esults support that Farp1 interacts with the Neuropilin-1/PlexinA1 complex and colocalizes with Plexi
188 he precursor, bound the VEGF-binding site of neuropilin-1; the C-terminal arginine (R(373)) of the se
190 screen identified the transmembrane protein neuropilin 2 (NRP2) and tetraspanin CD63 as factors for
191 and protein expression analysis showed that neuropilin 2 (NRP2), a key factor for vascular developme
193 guidance cue, Semaphorin 3F and its receptor Neuropilin 2 (Nrp2), influence dendritic spine maintenan
197 VEGF receptors, semaphorin 3F, neuropilin 1, neuropilin 2, podoplanin, and LYVE-1 by quantitative (re
198 A10 elevated genes, including neuropilin 1, neuropilin 2, slit2 and adenylyl cyclase-activating pept
199 d in neural and vascular patterning, such as neuropilin-2 (NETO2), a plexin domain containing recepto
200 mplex in brain with Sema3F receptor subunits Neuropilin-2 (Npn-2) and PlexinA3 (PlexA3) through an Np
201 Here we show that NrCAM interaction with neuropilin-2 (Npn-2) is critical for semaphorin 3F (Sema
202 guidance cue semaphorin 3F (Sema3F) and its neuropilin-2 (Npn-2)/plexinA3 (PlexA3) holoreceptor medi
203 ding Sema3F, and its holoreceptor components neuropilin-2 (Npn-2, also known as Nrp2) and plexin A3 (
205 ared the PBR sequence requirements for NCAM, neuropilin-2 (NRP-2), and synaptic cell adhesion molecul
209 eptors, plexins and neuropilins, among which neuropilin-2 (NRP2) is highly expressed in lymphatic end
213 the ability of ST8SiaIV/PST to polysialylate neuropilin-2 and SynCAM 1, suggesting that Arg(82) plays
214 and the O-glycan-containing linker region of neuropilin-2 are necessary and sufficient for its polysi
215 lylated at approximately 50% of the level of neuropilin-2 but not polysialylated when it lacks its cy
216 Our results show that floor plate-derived neuropilin-2 is developmentally regulated, functioning a
217 f floor plate-derived, but not axon-derived, neuropilin-2 is required for precrossing axon pathfindin
218 gnizes and docks on an acidic surface of the neuropilin-2 MAM domain to polysialylate O-glycans on th
226 he transmembrane nontyrosine kinase receptor neuropilin-2 was found to be essential for the VEGF-C-me
228 of its receptors, VEGFR-2, neuropilin-1, and neuropilin-2, in paraffin-embedded samples from 21 vesti
231 on of lymphatic endothelial cells (LEC) in a neuropilin-2-, plexin-D1-, and plexin-A1-dependent manne
234 a3G increased excitatory synapse density via neuropilin-2/PlexinA4 signaling and through activation o
235 SEMA3F acts on its coreceptors, plexins and neuropilins, among which neuropilin-2 (NRP2) is highly e
242 y, we found that the intracellular region of neuropilin and tolloid-like proteins (Neto) 1 and Neto2,
243 ified and characterized the Drosophila neto (neuropilin and tolloid-like) as an essential gene requir
246 KARs associate with the auxiliary proteins neuropilin- and tolloid-like 1 and 2 (Neto1 and Neto2),
251 class 3 semaphorin family, but VEGF164, the neuropilin-binding isoform of the classical vascular gro
252 circulation-independent, and mediated by the neuropilin-binding RXXK tissue-penetration peptide motif
253 By reconstituting all possible plexin and neuropilin combinations, we found that SEMA3F acts throu
256 nce molecules that signal through plexin and neuropilin coreceptors and since then have been establis
258 tial co-receptors/attachment factors such as neuropilins, heparan sulfate and sialic acids and the pu
261 ted that all known ligands and inhibitors of neuropilin interact with the b1 domain of neuropilin via
265 ro models, we show here that the alternative neuropilin ligand VEGF164 promotes the survival of migra
266 of retinal axons to Sema3D, Sema3E, or other neuropilin ligands at the midline, and consequently faci
269 Here, we determined that the discoidina neuropilin-like membrane protein DCBLD2 is upregulated i
270 Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is a neuropilin-related t
271 Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is up-regulated in the ne
272 ndantly through both its classical receptors neuropilin (NRP) 1 and, unconventionally, NRP2, while th
274 in the class 3 semaphorin (SEMA3) receptors neuropilin (NRP) 1 or 2 raised the possibility that each
275 eted glycoprotein SEMA3A binds its receptors neuropilin (NRP) 1 or NRP2 to position these axons for c
278 cular endothelial cadherin (VE-Cadherin) and neuropilin (NRP)-1 and 2, but not with junctional protei
279 transcription of VEGF receptor (VEGFR)-2 and neuropilin (NRP)-1, the primary receptors regulating end
280 ost & Microbe, Raaben et al. (2017) identify neuropilin (NRP)-2 as cell surface receptor and the tetr
286 (VEGF) signaling in tumor cells mediated by neuropilins (NRPs) contributes to the aggressive nature
288 al growth factor (VEGF) receptors, including neuropilins (NRPs), which regulate interstitial fluid fl
293 ibodies for VEGF receptor (VEGFR) 1 and 2 or neuropilin receptor 1 or by VEGFR2 inhibitors (SU 1498 a
294 lass 3 semaphorin SEMA3A signals through its neuropilin receptors, NRP1 and NRP2, to organise the axo
296 he developing cerebellum, genetic removal of Neuropilins reduces Hh signaling activity and suppresses
297 -derived neuropilin-like protein (ESDN) is a neuropilin-related transmembrane protein expressed in EC
298 sphodiesterase 4D (PDE4D) acts downstream of Neuropilins to control Hh transduction and medulloblasto